Impact of Screen Size on Colorectal Adenoma Detection
1 other identifier
interventional
656
1 country
1
Brief Summary
The purpose of this study is to assess whether the use of large screen during colonoscopy will increase adenoma detection rate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 2, 2021
CompletedFirst Posted
Study publicly available on registry
February 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2021
CompletedFebruary 11, 2021
February 1, 2021
12 months
February 2, 2021
February 6, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adenoma Detection Rate (ADR)
ADR is defined as the proportion of an endoscopist's screening colonoscopies in which one or more adenomas have been detected in patients
12 months
Secondary Outcomes (6)
Mean number of adenomas detected per colonoscopy
12 months
Mean number of sessile serrated polyps
12 months
Caecal intubation rate
12 months
Bowel cleansing level
12 months
Procedure Time
12 months
- +1 more secondary outcomes
Study Arms (2)
Large screen
ACTIVE COMPARATORThis is a high definition screen which gives a 76cm height and 67cm width (area: 5092cm2) endoscopic image.
Standard screen
NO INTERVENTIONThis is a high definition screen which gives a 37.5cm height and 32.5cm width (area: 1218.75cm2) endoscopic image.
Interventions
Large screen size is 4x larger than standard screen, we hope that the colonoscopies carried out with large screens will confer to better lesion detection
Eligibility Criteria
You may qualify if:
- Patients aged 18 years or above
- Referred to the endoscopy unit for diagnostic or surveillance colonoscopy
You may not qualify if:
- Familial history of Familial adenomatous polyposis or Hereditary non-polyposis colorectal cancer
- Known history of inflammatory bowel disease
- Emergency endoscopy of any nature (such as for gastrointestinal bleeding, assessment of large bowel investigation and colonic decompression)
- Patients with colostomy
- Previously incomplete colonoscopy (not including insufficient preparation)
- Patients with known palliative colorectal malignant disease Patients with coagulopathies Inability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince of Wales Hospital
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
February 2, 2021
First Posted
February 11, 2021
Study Start
July 1, 2020
Primary Completion
June 30, 2021
Study Completion
August 31, 2021
Last Updated
February 11, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share